Can Knowledge From Treating Chronic Myeloid Leukemia Inform Therapy of <i>EGFR</i>-Mutant Lung Adenocarcinoma?

This Viewpoint discusses how therapy of chronic myeloid leukemia can inform therapy of lung cancer.

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2025-02-20
DOI
https://doi.org/10.1001/jamaoncol.2024.6727
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can Knowledge From Treating Chronic Myeloid Leukemia Inform Therapy of EGFR-Mutant Lung Adenocarcinoma?

Robert Peter Gale
JAMA Oncology
Lung Cancer Treatments and Mutations
article

Can Knowledge From Treating Chronic Myeloid Leukemia Inform Therapy of EGFR-Mutant Lung Adenocarcinoma?

Robert Peter Gale
article en

Abstract

This Viewpoint discusses how therapy of chronic myeloid leukemia can inform therapy of lung cancer.

JAMA OncologyVol. 11(4)
Imperial College London (GB)
Good health and well-being
Openalex Percentile: Top 95%
Lung Cancer Treatments and Mutations
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Can Knowledge From Treating Chronic Myeloid Leukemia Inform Therapy of <i>EGFR</i>-Mutant Lung Adenocarcinoma? — Robert Peter Gale · JAMA Oncology (2025) | TGRS Research Map | TGRS